Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases

Researchers from West Virginia University College of Law have conducted a study examining the frequency of drug patent invalidations based on inequitable conduct. The findings, published in JAMA, shed light on the impact of fraud or deceit in obtaining patents related to Food and Drug Administration (FDA)-regulated products. The study reveals a significant rise in […] Source

Om Podcasten

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management